CMPS NASDAQ
COMPASS Pathways plc
1W: -3.4%
1M: -17.0%
3M: +17.6%
YTD: +72.1%
1Y: +157.9%
3Y: +25.8%
5Y: -68.5%
$10.85
-0.42 (-3.73%)
Weekly Expected Move ±10.0%
$9
$10
$11
$12
$14
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$1.5B
52W Range3.92-15.4
Volume2,621,738
Avg Volume4,567,676
Beta2.49
Dividend—
Analyst Ratings
Company Info
CEOKabir Kumar Nath
Employees156
SectorHealthcare
IndustryBiotechnology
IPO Date2020-09-18
Websitecompasspathways.com
33 Broadwick Street
London, CH W1F 0DQ
GB
London, CH W1F 0DQ
GB
44 64 6905 3974
About COMPASS Pathways plc
COMPASS Pathways plc is a mental healthcare company with a primary presence in the United Kingdom and the United States. Established in 2020 and headquartered in London, UK, the firm focuses on developing novel treatments. Its key product is COMP360, an investigational psilocybin therapy. This therapy has advanced through Phase IIb clinical trials for treatment-resistant depression and is currently undergoing Phase II trials for post-traumatic stress disorder. The company previously operated under the name COMPASS Rx Limited before rebranding to COMPASS Pathways plc in August 2020.
Latest News
Eli Lilly Is Acquiring a Psychedelic Medicine Biotech. Here's What You Need to Know.
Notable healthcare headlines for the week: UnitedHealth, J&J, and Intuitive Surgical in focus
At a glance: stocks gapping up premarket
Is COMPASS Pathways plc (CMPS) Stock a Psychedelic Medicine Opportunity After Positive COMP360 Data?
$CMPS Compass Pathways: A Structural Mispricing in Plain Sight?
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Riley Wayne Joseph | A-Award | 21,110 | $11.85 | 2026-05-27 |
| McQuade Robert | A-Award | 21,110 | $11.85 | 2026-05-27 |
| Norton David Y | A-Award | 21,110 | $11.85 | 2026-05-27 |
| Tregoning Kathleen | A-Award | 41,119 | $11.85 | 2026-05-27 |
| Tregoning Kathleen | 0 | — | 2026-05-27 |